Cargando…

Serum podocalyxin levels correlate with carotid intima media thickness, implicating its role as a novel biomarker for atherosclerosis

Podocalyxin is a cell surface sialomucin, which is expressed in not only glomerular podocytes but also vascular endothelial cells. Urinary podocalyxin is used as a marker for glomerular disease. However, there are no reports describing serum podocalyxin (s-Podxl) levels. Therefore, the association b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shoji, Mayumi, Takemoto, Minoru, Kobayashi, Kazuki, Shoji, Toshihiro, Mori, Satoka, Sagara, Jun-ichi, Kurosawa, Hiroyuki, Hirayama, Yoshiaki, Sakamoto, Kenichi, Ishikawa, Takahiro, Koshizaka, Masaya, Maezawa, Yoshiro, Yokote, Koutaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762903/ https://www.ncbi.nlm.nih.gov/pubmed/29321582 http://dx.doi.org/10.1038/s41598-017-18647-6

Ejemplares similares

Werner syndrome: a model for sarcopenia due to accelerated aging
por: Yamaga, Masaya, et al.
Publicado: (2017)

Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus
por: Ishikawa, Takahiro, et al.
Publicado: (2017)

N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study
por: Ide, Kana, et al.
Publicado: (2018)

Lifetime extension and the recent cause of death in Werner syndrome: a retrospective study from 2011 to 2020
por: Kato, Hisaya, et al.
Publicado: (2022)

Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes
por: Maezawa, Yoshiro, et al.
Publicado: (2015)

Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries
por: Sakamoto, Kenichi, et al.
Publicado: (2015)

Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study
por: Koshizaka, Masaya, et al.
Publicado: (2020)

Optical coherence tomography findings in three patients with Werner syndrome
por: Nagai, Tatsuya, et al.
Publicado: (2022)

Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events
por: Maezawa, Yoshiro, et al.
Publicado: (2023)

Time gap between the onset and diagnosis in Werner syndrome: a nationwide survey and the 2020 registry in Japan
por: Koshizaka, Masaya, et al.
Publicado: (2020)

Human glomerular transcriptome of diabetic kidneys: Can the podocyte cytoskeleton be a therapeutic target?
por: Maezawa, Yoshiro, et al.
Publicado: (2018)

Multidrug use positively correlates with high-risk prescriptions in the Japanese elderly: a longitudinal study
por: Arai, Sayaka, et al.
Publicado: (2019)

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)
por: Koshizaka, Masaya, et al.
Publicado: (2019)

Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME‐V study)
por: Koshizaka, Masaya, et al.
Publicado: (2020)

Urinary Podocalyxin as a Biomarker to Diagnose Membranous Nephropathy
por: Imaizumi, Takahiro, et al.
Publicado: (2016)

A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammation
por: Ishibashi, Ryoichi, et al.
Publicado: (2016)

Correction of Hypercortisolemia with an Improved Cognitive Function and Muscle Mass after Transsphenoidal Surgery in an Older Patient with Cushing's Disease
por: Terayama, Ryo, et al.
Publicado: (2022)

Updates on dyslipidemia in patients with diabetes
por: Ide, Shintaro, et al.
Publicado: (2023)

Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin
por: Hara, M., et al.
Publicado: (2012)

Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint phase IV randomised controlled trial (PRIME-V study)
por: Koshizaka, Masaya, et al.
Publicado: (2017)

Renal dysfunction, malignant neoplasms, atherosclerotic cardiovascular diseases, and sarcopenia as key outcomes observed in a three-year follow-up study using the Werner Syndrome Registry
por: Maeda, Yukari, et al.
Publicado: (2023)

Imeglimin‐mediated glycemic control in maternally inherited deafness and diabetes
por: Ishibashi, Ryoichi, et al.
Publicado: (2023)

Novel mechanism of increasing cerebral vascular constriction in acute hyperglycemia and diabetes through adenylyl cyclase 5‐generated cyclic adenosine monophosphate
por: Sakamoto, Kenichi, et al.
Publicado: (2019)

Fibroblasts from different body parts exhibit distinct phenotypes in adult progeria Werner syndrome
por: Kato, Hisaya, et al.
Publicado: (2021)

Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
por: Takatsuna, Yoko, et al.
Publicado: (2020)

An Angiotensin II Type 1 Receptor Blocker Prevents Renal Injury via Inhibition of the Notch Pathway in Ins2 Akita Diabetic Mice
por: Koshizaka, Masaya, et al.
Publicado: (2012)

Sitagliptin Improves Postprandial Hyperglycemia by Inhibiting Glucagon Secretion in Werner Syndrome With Diabetes
por: Watanabe, Kaneyuki, et al.
Publicado: (2013)

Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium
por: Shoda, Jumpei, et al.
Publicado: (2022)

Sitagliptin Successfully Ameliorates Glycemic Control in Werner Syndrome With Diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2012)

Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats
por: Takeda, Kenji, et al.
Publicado: (2021)

Helicobacter cinaedi infection in patients with diabetes: a case report
por: Ishibashi, Ryoichi, et al.
Publicado: (2015)

Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus
por: Tatsumi, Tomoaki, et al.
Publicado: (2022)

Antihypertensive Effects of Esaxerenone in Older Patients with Primary Aldosteronism
por: Fujimoto, Masanori, et al.
Publicado: (2023)

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial
por: Yokoh, Hidetaka, et al.
Publicado: (2015)

Podocalyxin in Normal Tissue and Epithelial Cancer
por: Le Tran, Ngoc, et al.
Publicado: (2021)

Is obesity an absolute evil? Increase in adipose tissue does not always decrease insulin sensitivity
por: Ishikawa, Ko, et al.
Publicado: (2014)

Physician-initiated clinical study of limb ulcers treated with a functional peptide, SR-0379: from discovery to a randomized, double-blind, placebo-controlled trial
por: Nakagami, Hironori, et al.
Publicado: (2018)

Role of podocalyxin in astrocytoma: Clinicopathological and in vitro evidence
por: HUANG, TIANXIANG, et al.
Publicado: (2013)

Podocalyxin regulates pronephric glomerular development in zebrafish
por: Ichimura, Koichiro, et al.
Publicado: (2013)

Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sqaod4q3fcjvah2fi60h35kuo3